Related Experiment Video
Updated: Jun 26, 2026
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
Cryoablation for renal tumors: current status
Andre Berger1, Kazumi Kamoi, Inderbir S Gill
1Center for Laparoscopic and Robotic Surgery, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Purpose Of Review:
To review the evolution and current status of cryoablation for renal tumors.
Recent Findings:
Cryoablation is the most evaluated probe ablative method for the treatment of small renal masses. It is associated with high efficacy and low morbidity. New data on intermediate and long-term oncological outcomes are now available. Five and 10-year cancer-specific survival are 93 and 81%, respectively. Renal cryoablation is most commonly performed percutaneously or laparoscopically. Recently, single-port laparoscopic and natural orifice transluminal endoscopic surgery approaches have also been employed for renal cryotherapy.
Summary:
With careful patient selection, the intermediate-term and long-term oncologic outcomes after cryoablation for kidney tumors are satisfactory. Combination with new technologies and further development of imaging techniques can potentially expand the range of indications of the procedure.
